The following athletes earned All-Knox Morrow Athletic Conference honors for 2024-25 this winter: More on Cardington boys ...
Lenacapavir' was developed by Gilead Sciences, a research-based biopharmaceutical company in the US, as a pre-exposure prophylaxis (PrEP) medication to prevent infection in people at risk of exposure ...
Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...
Renaissance Technologies' 13F reveals shifts in a $67.6B portfolio with notable changes in Palantir, Novo Nordisk, and NVIDIA ...
Zacks Investment Research on MSN11hOpinion
These 3 Attractive Stocks Keep Cruising Higher
The market has thrown a tantrum over recent weeks, with tariff talks and other potential economic implications shaking ...
Academy Award winning filmmaker Martin Scorsese ( Taxi Driver , Goodfellas , Killers of the Flower Moon ) has signed on to ...
Gilead (GILD) stock in focus as its HIV anti-viral lenacapavir shows promise in HIV prevention with once-yearly PrEP ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of ...
Gilead said two experimental once-a-year versions of its HIV prevention shot lenacapavir passed muster in an early-stage ...
Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC that the market rally that ...
In 2024, technology stocks involved in artificial intelligence (AI) led the Nasdaq-100 index higher, while healthcare stocks ...